Entry |
|
Name |
Etoricoxib (USAN/INN) |
Formula |
C18H15ClN2O2S
|
Exact mass |
358.0543
|
Mol weight |
358.84
|
Structure |
|
Simcomp |
|
Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
|
Remark |
|
Efficacy |
Analgesic, Anti-inflammatory, COX-2 inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AH Coxibs
M01AH05 Etoricoxib
D03710 Etoricoxib (USAN/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
D03710 Etoricoxib
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS2 (COX2)
D03710 Etoricoxib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 24
1 C8y C 34.0368 -17.8232
2 C8y C 31.5907 -16.4254
3 C8x C 31.5907 -17.8232
4 C8x C 32.7788 -18.5221
5 C8x C 34.0368 -16.4254
6 C8x C 32.7788 -15.7265
7 S4a S 30.4025 -15.7265
8 C1a C 29.1445 -15.0276
9 O3c O 31.1014 -14.5384
10 O3c O 29.7036 -16.9146
11 C8y C 35.2415 -18.5321
12 C8y C 35.2299 -19.9199
13 N5x N 36.4346 -20.6289
14 C8x C 37.6509 -19.9400
15 C8y C 37.6625 -18.5522
16 C8x C 36.4578 -17.8433
17 C8y C 34.0098 -20.6108
18 C8x C 32.8288 -19.9156
19 C8x C 31.5424 -20.6043
20 C8y C 31.6006 -22.0020
21 N5x N 32.7817 -22.6972
22 C8x C 33.9979 -22.0086
23 C1a C 30.3705 -22.6984
24 X Cl 38.8982 -17.8528
BOND 26
1 2 3 2
2 3 4 1
3 4 1 2
4 1 5 1
5 5 6 2
6 2 6 1
7 2 7 1
8 7 8 1
9 7 9 2
10 7 10 2
11 1 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 14 15 1
16 15 16 2
17 11 16 1
18 12 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 17 22 1
25 20 23 1
26 15 24 1
|